Table 2.
Assessment of Scheltens ischemic rating scales in T2DM and normal subjects.
| Type 2 Diabetes (N = 35) | Normal (N = 37) | P1 | P2 | |
|---|---|---|---|---|
| PVH | 2.63 ± 0.35 | 1.79 ± 0.32 | 0.082 | 0.236 |
| WMH | 4.49 ± 0.83 | 2.09 ± 0.36 | 0.011 | 0.023 |
| BG | 1.34 ± 0.34 | 0.54 ± 0.16 | 0.038 | 0.056 |
| ITF | 0.34 ± 0.11 | 0.06 ± 0.04 | 0.017 | 0.032 |
| Total ischemic scores | 8.8 ± 1.38 | 4.31 ± 0.68 | 0.005 | 0.013 |
BG: basal ganglia; ITF: infratentorial foci; PVH: periventricular hyperintensities; WMH: lobar white matter hyperintensities.
Data are presented as mean ± SEM. P < 0.05 (shown in italics) for T2D versus normal subjects. P1 values were calculated by independent t-test. P2 values were calculated by ANCOVA adjusted by age, gender, education, and hypertension.